Gap years in new government rules seen as particular concern for Jewish women.
Special To The Jewish Week
Mention the new breast cancer guidelines, and D.J. Schneider Jensen utters a single syllable of disgust. “Uhk!” Like many Jewish women who carry a BRCA genetic mutation or have a personal history of breast cancer, Jensen was appalled by controversial recommendations issued five months ago by the U.S. Preventive Services Task Force of the U.S. Department of Health & Human Services. The new guidelines advise against mammograms until the age of 50, and against teaching self breast exams to women
In late 2002, when our Joshua Venture Group (JVG) cohort was announced, the term “Jewish social entrepreneur” did not yet roll easily off the tongue. There was no “innovation ecosystem” to speak of, few incubators interested in helping us grow our ventures, and little confidence that Jewish life could or should blossom outside of existing institutional frameworks. JVG was founded to help emerging leaders change the Jewish world with their ideas.
When Sarah tested positive for the BRCA1 breast cancer gene five years ago, her decision to have both her breasts removed was a simple one — her mother had died of the disease at the devastatingly young age of 42 and her grandmother at 49.